PGNY is expected to report earnings to fall 66.72% to 14 cents per share on October 31
Q3'24
Est.
$0.14
Q2'24
Beat
by $0.26
Q1'24
Beat
by $0.26
Q4'23
Beat
by $0.22
Q3'23
Beat
by $0.05
The last earnings report on August 06 showed earnings per share of 43 cents, beating the estimate of 17 cents. With 1.84M shares outstanding, the current market capitalization sits at 3.52B.
a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools